# Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)

> **NCT03042143** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Belfast Health and Social Care Trust** · enrollment: 129 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **BIOLOGICAL:** Human umbilical cord derived CD362 enriched MSCs
- **BIOLOGICAL:** Placebo (Plasma-Lyte 148)

## Key facts

- **NCT ID:** NCT03042143
- **Lead sponsor:** Belfast Health and Social Care Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-07
- **Primary completion:** 2026-04
- **Final completion:** 2026-10
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042143, "Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03042143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*